Primary Membranous Nephropathy

Nephrology

7 drugs in development·7 companies·6 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
alxn1920	ALEXION PHARMACEUTICALS, INC. (ALXN)
Belimumab	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 2(3)

Drug	Company
ALXN1920	ARS Pharmaceuticals, Inc. (SPRY)
budoprutug	Climb Bio, Inc. (CLYM)
Felzartamab	BIOGEN INC. (BIIB)

Phase 1(1)

Drug	Company
povetacicept	VERTEX PHARMACEUTICALS INC / MA (VRTX)

Phase 2/Phase 3(1)

Drug	Company
Tacrolimus	BeOne Medicines Ltd. (ONC)

BioSniper tracks 7 drugs in development for Primary Membranous Nephropathy across 7 companies.

There are 6 clinical trials targeting Primary Membranous Nephropathy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.